The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell

Li Chiyang, Yang Fan, Yang Yue, Lu Yuntao, Zhou Qiang

Chinese Journal of Clinical Anatomy ›› 2022, Vol. 40 ›› Issue (5) : 562-568.

PDF(5356 KB)
PDF(5356 KB)
Chinese Journal of Clinical Anatomy ›› 2022, Vol. 40 ›› Issue (5) : 562-568. DOI: 10.13418/j.issn.1001-165x.2022.5.11

The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell

  • Li Chiyang, Yang Fan, Yang Yue, Lu Yuntao, Zhou Qiang*
Author information +
History +

Abstract

Objective    To clarify the correlation between CBX3 and the prognosis of glioma by analyzing the expression of CBX3 in the glioma public database. Flow cytometry and the detection of apoptosis indexes were used to analyze its effect on the apoptosis level of glioma cell lines.   Methods   By analyzing the data of glioma patients gene chip in TCGA and CGGA, the expression of CBX3 in different grades of glioma was compared and the relationship between CBX3 expression and prognosis of glioma patients was analyzed. Functional annotation of the CBX3 gene by GO and Pathway analysis. Finally, the effect of CBX3 gene on the apoptosis level of glioma cell lines was explored in cell lines.  Results  The expression of CBX3 in high-grade gliomas was significantly higher than that in low-grade gliomas (P<0.01). The prognosis of patients with high CBX3 expression was worse than that of patients with low CBX3 expression (P<0.05). At the same time, flow cytometry experiments showed that overexpression of CBX3 could significantly reduce the apoptosis level of glioblastoma cell lines U87MG and T98G.   Conclusion   The expression level of CBX3 is negatively correlated with the survival time of glioma. High expression of CBX3 can reduce the apoptosis level of glioblastoma cell lines, so CBX3 may be an effective indicator for judging the prognosis of glioblastoma.

Key words

Glioblastoma;  /   / CBX3;  /   / Bioinformatics analysis;  /   / Prognosis

Cite this article

Download Citations
Li Chiyang, Yang Fan, Yang Yue, Lu Yuntao, Zhou Qiang. The expression of CBX3 in brain glioma and its influence on the apoptosis of glioma cell[J]. Chinese Journal of Clinical Anatomy. 2022, 40(5): 562-568 https://doi.org/10.13418/j.issn.1001-165x.2022.5.11

References

[1] Zhou Q, Li JJ, Wang H, et al. TPD52L2 impacts proliferation, invasiveness and apoptosis of glioblastoma cells via modulation of wnt/β-catenin/snail signaling[J].Carcinogenesis,2018,39(2):214-224. DOI:10.1093/carcin/bgx125.
[2] Xu S, Tang L, Li X ,et al. Immunotherapy for glioma: Current management and future application[J].Cancer Lett,2020,476:1-12. DOI: 10.1016/j.canlet.2020.02.002.
[3] Zhang N, Zhang H, Wang ZY, et al. Immune infiltrating cells-derived risk signature based on large-scale analysis defines immune landscape and predicts immunotherapy responses in glioma tumor microenvironment[J]. Front Immunol, 2021,12:691811. DOI: 10.3389/fimmu.2021.691811.
[4]  Yue X,  Lan FM,  Xia TY, Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt/β-catenin signaling and promotes radiation resistance by targeting TCEAL7[J]. Mol Ther, 2019, 27(11):1939-1949. DOI: 10.1016/j.ymthe.2019.07.011.
[5] Zhong X, Kan A,Zhang W, et al.CBX3/HP1γ promotes tumor proliferation and predicts poor survival in hepatocellular carcinoma[J]. Aging (Albany NY), 2019, 11(15):5483-5497. DOI: 10.18632/aging.102132.
[6]  Miller AM,  Shah RH,  Pentsova EI, et al. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid[J]. Nature, 2019, 565(7741):654-658. DOI: 10.1038/s41586-019-0882-3.
[7]  Lin H, Lian J, Xia L, et al. CBX3 Promotes Gastric Cancer Progression and Affects Factors Related to Immunotherapeutic Responses[J].Cancer Manag Res, 2020,12:10113-10125. DOI: 10.2147/CMAR.S271807.
[8]  Zhao SP,  Wang F,  Yang M, et al. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis[J].J Neurooncol, 2019,145(1):35-48. DOI: 10.1007/s11060-019-03286-w.
[9]  吴亚辉,王韬甫,林洪启,基于JAK2/STAT3信号通路观察右美托咪定减轻大鼠心肌缺血再灌注损伤和抑制凋亡作用机制[J]. 中国临床解剖学杂志, 2022, 40(1): 55-61. DOI:10.13418/j.issn.1001-165x. 2022.1.11.
[10] Smallwood A,  Hon GC,  Jin F, et al. CBX3 regulates efficient RNA processing genome-wide[J]. Genome Res, 2012, 22(8):1426-36. DOI: 10.1101/gr.124818.111.
[11] Zhang H, Chen W,  Fu X, et al. CBX3 promotes tumor proliferation by regulating G1/S phase via p21 downregulation and associates with poor prognosis in tongue squamous cell carcinoma[J].Gene, 2018, 654:49-56. DOI: 10.1016/j.gene.2018.02.043.
[12]Ruan J, Ouyang H,  Amaya MF, et al. Structural basis of the chromodomain of Cbx3 bound to methylated peptides from histone h1 and G9a[J].PLoS One, 2012, 7(4):e35376. DOI: 10.1371/journal.pone.0035376.
[13]Zaidan NZ, Sridharan R. HP1γ regulates H3K36 methylation and pluripotency in embryonic stem cells[J].Nucleic Acids Res, 2020, 48(22):12660-12674. DOI: 10.1093/nar/gkaa1091.
[14]D'Angelo F, Ceccarelli M, Tala, et al.The molecular landscape of glioma in patients with Neurofibromatosis 1[J].Nat Med, 2019, 25(1):176-187. DOI: 10.1038/s41591-018-0263-8.
PDF(5356 KB)

Accesses

Citation

Detail

Sections
Recommended

/